We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$44.9B
AUM Growth
+$1.51B
Cap. Flow
-$3.93B
Cap. Flow %
-8.75%
Top 10 Hldgs %
9.25%
Holding
1,161
New
143
Increased
326
Reduced
483
Closed
121

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$163M
2
HRI icon
Herc Holdings
HRI
+$160M
3
VYX icon
NCR Voyix
VYX
+$155M
4
APTV icon
Aptiv
APTV
+$147M
5
XLNX
Xilinx Inc
XLNX
+$141M

Sector Composition

Rank Sector Weight
1 Financials 18.3%
2 Industrials 13.62%
3 Healthcare 11.97%
4 Energy 8.91%
5 Consumer Discretionary 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CINF icon
901
Cincinnati Financial
CINF
$28.3B
$2.18M ﹤0.01%
41,624
-3,300
-7% -$167K
INVA icon
902
Innoviva
INVA
$1.61B
$2.08M ﹤0.01%
72,514
-342,986
-83% -$10M
SWH
903
DELISTED
Stanley Black & Decker, Inc.
SWH
$2.06M ﹤0.01%
+20,000
New +$2.05M
QEP
904
DELISTED
QEP RESOURCES, INC.
QEP
$2.01M ﹤0.01%
65,600
-74,700
-53% -$2.34M
AIV
905
Aimco
AIV
$375M
$2.01M ﹤0.01%
581,777
+30,778
+6% +$110K
MWW
906
DELISTED
Monster Worldwide Inc
MWW
$1.97M ﹤0.01%
276,795
-3,990
-1% -$20.9K
KMG
907
DELISTED
KMG Chemicals Inc
KMG
$1.97M ﹤0.01%
116,551
-36,900
-24% -$715K
ECPG icon
908
Encore Capital Group
ECPG
$2.06B
$1.97M ﹤0.01%
39,105
-75,469
-66% -$3.59M
KEY.PRG
909
DELISTED
KeyCorp Pfd
KEY.PRG
$1.93M ﹤0.01%
14,945
+1,123
+8% +$143K
OPCH icon
910
Option Care Health
OPCH
$3.53B
$1.85M ﹤0.01%
62,400
-14,900
-19% -$421K
BPOP icon
911
Popular Inc
BPOP
$11.1B
$1.83M ﹤0.01%
63,700
+12,900
+25% +$349K
LEA icon
912
Lear
LEA
$7.45B
$1.81M ﹤0.01%
+22,400
New +$1.75M
TNGO
913
DELISTED
Tangoe, Inc.
TNGO
$1.81M ﹤0.01%
100,563
-184,000
-65% -$3.49M
USPH icon
914
US Physical Therapy
USPH
$1.2B
$1.75M ﹤0.01%
49,599
-51,450
-51% -$1.68M
CPB icon
915
Campbell Soup
CPB
$6.8B
$1.75M ﹤0.01%
40,369
-6,600
-14% -$273K
IBN icon
916
ICICI Bank
IBN
$109B
$1.75M ﹤0.01%
258,500
+1,650
+0.6% +$10.5K
SMRT
917
DELISTED
Stein Mart Inc
SMRT
$1.72M ﹤0.01%
128,100
-30,033
-19% -$434K
BXP icon
918
Boston Properties
BXP
$11.2B
$1.66M ﹤0.01%
16,500
+1,600
+11% +$165K
RVBD
919
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
$1.59M ﹤0.01%
+87,800
New +$1.42M
RCPT
920
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$1.55M ﹤0.01%
+53,316
New +$1.43M
DDS icon
921
Dillards
DDS
$9.2B
$1.53M ﹤0.01%
+15,700
New +$1.36M
TGNA
922
DELISTED
TEGNA Inc
TGNA
$1.51M ﹤0.01%
97,298
+13,763
+16% +$194K
THG icon
923
Hanover Insurance
THG
$7.84B
$1.48M ﹤0.01%
24,707
+2,500
+11% +$147K
MKTO
924
DELISTED
MARKETO INC COM STK (DE)
MKTO
$1.43M ﹤0.01%
38,659
-88,239
-70% -$2.91M
CTRL
925
DELISTED
Control4 Corporation
CTRL
$1.42M ﹤0.01%
+79,943
New +$1.32M

Similar funds

Lord, Abbett & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Lord, Abbett & Co held 1,161 positions worth $44.9B, up 3.5% from $43.4B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Lord, Abbett & Co withdrew a net $3.93B in Q4 2013, closing 121 positions and reducing 483 holdings. Its most notable exit was Labcorp, an estimated $163M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lord, Abbett & Co opened a new position in American Airlines Group worth $129M.

  • Lord, Abbett & Co's largest Q4 2013 buy was American Airlines Group: 5,122,124 shares worth $129M.
  • Lord, Abbett & Co added most to Gilead Sciences in Q4 2013, an estimated $241M increase.
  • Lord, Abbett & Co's biggest Q4 2013 reduction was Herc Holdings, cutting an estimated $160M.
  • Lord, Abbett & Co fully exited Labcorp in Q4 2013, selling an estimated $163M.
  • Lord, Abbett & Co's ten largest holdings make up 9.3% of its $44.9B portfolio in Q4 2013.
  • Lord, Abbett & Co opened 143 new positions and closed 121 in Q4 2013.
  • Lord, Abbett & Co's portfolio value rose 3.5% quarter-over-quarter to $44.9B.

Based on Lord, Abbett & Co's 13F filing for Q4 2013, filed 14 Feb 2014.